Mineralys Therapeutics, Inc.

Mineralys Therapeutics is a drug development company working on a medicine called lorundrostat to treat heart and kidney diseases. The company focuses on conditions where the body produces too much of a hormone called aldosterone, which can cause high blood pressure, chronic kidney disease, and sleep apnea. Lorundrostat is a pill that blocks the enzyme responsible for making aldosterone. The company was founded in 2019 and is based in Pennsylvania.